Literature DB >> 9240963

Advances in adenoviral vectors: from genetic engineering to their biology.

P Yeh1, M Perricaudet.   

Abstract

Ad2 and Ad5 belong to a group of human cytolytic viruses that target the respiratory airways for reproduction, whereas latent infections establish within other tissues. Signals therefore exist that control this dichotomic process in different cell types, perhaps including cis and/or trans elements of viral origin. Since 1993, Ad2- and Ad5-based adenoviruses lacking all or part of the E1 regulatory region have been undergoing evaluation in phase I trials that target cancer and cystic fibrosis. These viruses are extremely attenuated and actually do not reproduce in most human cells. However, they retain most of the virus genetic program and often promote a significant cytotoxicity after infection, emphasizing the need to further cripple the virus biology to extend the duration of transgene expression, if required. We will review the strategies currently followed to engineer a professional lytic virus for epithelial cells into an innocuous gene delivery vehicle. Potential effects on the transducing properties of the vector that may result from the inactivation of viral activities that normally allow/regulate extrachromosomal gene expression during wild-type infection are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240963     DOI: 10.1096/fasebj.11.8.9240963

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Frequency and stability of chromosomal integration of adenovirus vectors.

Authors:  A Harui; S Suzuki; S Kochanek; K Mitani
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 3.  Gene therapy for type 1 diabetes: is it ready for the clinic?

Authors:  Antonella D'Anneo; Pleunie Rood; Rita Bottino; A N Balamurugan; Jing He; Nick Giannoukakis
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Assessment of hazard risk associated with the intravenous use of viral vectors in rodents.

Authors:  Jon D Reuter; Xiaoqun Fang; Christina S Ly; Karen K Suter; Daniel Gibbs
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

5.  Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.

Authors:  F Griscelli; H Li; A Bennaceur-Griscelli; J Soria; P Opolon; C Soria; M Perricaudet; P Yeh; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.

Authors:  W P Halford; C D Kemp; J A Isler; D J Davido; P A Schaffer
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 7.  Cas9 as a versatile tool for engineering biology.

Authors:  Prashant Mali; Kevin M Esvelt; George M Church
Journal:  Nat Methods       Date:  2013-10       Impact factor: 28.547

Review 8.  Gene delivery to the airway.

Authors:  Nicholas W Keiser; John F Engelhardt
Journal:  Curr Protoc Hum Genet       Date:  2013-07

9.  Two-helper RNA system for production of recombinant Semliki forest virus particles.

Authors:  C Smerdou; P Liljeström
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice.

Authors:  Eric A Levicoff; Joseph S Kim; Satoshi Sobajima; Corey J Wallach; James W Larson; Paul D Robbins; Xiao Xiao; Li Juan; Gianluca Vadala; Lars G Gilbertson; James D Kang
Journal:  Spine (Phila Pa 1976)       Date:  2008-06-15       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.